Rachel is a Consultant Pharmacist for Neurology at Imperial College NHS Trust in London where she is also the clinical lead for the Neurosciences Treatment Unit. She has been an NHS hospital pharmacist for more than 30 years and working as a neurology specialist pharmacist for most of this time. She works as part of the MS team at Imperial on the safe provision of medicines to MS patients and has overseen the development of a pharmacy-led DMT prescribing & montoring service at the trust. She is a non-medical prescriber of DMTs in MS & runs a clinic discussing DMT choices with pwMS.

Rachel is credentialled by the Royal College of Pharmacy as a consultant pharmacist. She is chair of the UKCPA (United Kingdom Clinical Pharmacist Association) Neurosciences committee. She is on the MS Trust professional advisory board and has also worked extensively with NHS England as part of the MS working group looking at the commissioning of MS DMTs & the provision of MS services in England.